Clinical Trial Update: Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing prednisone versus dexamethasone as initial therapy for newly diagnosed, untreated immune thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Nonneoplastic Condition | Phase 3 | Status: COMPLETED